Ira Finegold, MD
Allergy · White Plains, NYNPI 1902982085
Payments from drug & device makers
Across 667 payments — averaging $42.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$16K
- GSK$3K
- Genentech USA, Inc.$2K
- Sanofi$2K
- Novartis$920
- Blueprint Medicines Corporation$677
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 173 | $15,536 |
| GSK | 189 | $3,247 |
| Genentech USA, Inc. | 22 | $2,345 |
| Sanofi | 57 | $1,800 |
| Novartis | 49 | $920 |
| Blueprint Medicines Corporation | 16 | $677 |
| Regeneron Healthcare Solutions, Inc. | 17 | $515 |
| Amgen | 20 | $477 |
| Greer Laboratories, Inc. | 12 | $391 |
| Alk-abello, Inc | 15 | $267 |
| Teva Pharmaceuticals USA, Inc. | 9 | $238 |
| Kaleo, Inc. | 12 | $230 |
| Optinose US, Inc. | 10 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $206 |
| Covis Pharma GmbH | 9 | $201 |
| Sanofi-aventis U.S. LLC | 5 | $179 |
| Pfizer | 7 | $172 |
| Mylan Specialty L.p. | 7 | $148 |
| LEO Pharma Inc. | 5 | $98 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Pharming Healthcare, Inc. | 2 | $57 |
| Boehringer Ingelheim | 2 | $53 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $45 |
| Incyte Corporation | 3 | $44 |
| Abbott | 2 | $41 |
| Grifols USA, LLC | 2 | $36 |
| AbbVie | 2 | $34 |
| Biocryst US Sales Co., LLC | 2 | $31 |
| CSL Behring | 1 | $29 |
| Organon | 1 | $27 |
| USWM, LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $17 |
How this compares
$28,378 in reported general payments places this provider in the 80th percentile of 92 allergy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in White Plains
- Noreen LinnWhite Plains$11K
- Christopher SmithHorseheads$18M
- Marc BraunsteinHewlett$924K
- Allison RamseyRochester$904K
- Dariusz ChrostowskiWatertown$751K
- Anne MaitlandTarrytown$626K
- Yudhistira PersaudBronx$280K
- Alan KaufmanMount Vernon$227K
- Michael KatlanAlbany$91K
- Michel AklJamestown$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.